Clinical Trial Update: A Study of MK-8189 in Participants With Bipolar I Disorder (MK-8189-020) [Phase 1]

View source ↗

Summary

Phase 1 results from a Merck-sponsored study of MK-8189 in participants with Bipolar I Disorder have been completed and results posted on 2025-08-17. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• MK-8189

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bipolar I Disorder | Phase 1 | Status: COMPLETED | Results posted: 2025-08-17